Characteristics of Patients With Recessive Dystrophic Epidermolysis Bullosa
| Status: | Recruiting |
|---|---|
| Conditions: | Skin and Soft Tissue Infections |
| Therapuetic Areas: | Dermatology / Plastic Surgery |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 7/21/2018 |
| Start Date: | November 2009 |
| End Date: | December 2021 |
| Contact: | Irene Bailey-Healy |
| Email: | baileyhi@stanford.edu |
| Phone: | (650) 721-7149 |
Recessive dystrophic epidermolysis bullosa (RDEB) is a disease caused by genetic mutations in
the gene for type VII collagen. Patients with RDEB develop large, severely painful blisters
and open wounds from minor trauma to their skin. We are screening subjects with RDEB to
evaluate characteristics of the subjects and their cells in order to develop new strategies
of therapy and determine whether subjects could be candidates for treatment studies.
the gene for type VII collagen. Patients with RDEB develop large, severely painful blisters
and open wounds from minor trauma to their skin. We are screening subjects with RDEB to
evaluate characteristics of the subjects and their cells in order to develop new strategies
of therapy and determine whether subjects could be candidates for treatment studies.
Inclusion Criteria:
- Clinical diagnosis of RDEB by local dermatologist
- 7 years of age or older
Exclusion Criteria:
-Medical instability limiting ability to travel to Stanford University Medical Center
We found this trial at
1
site
291 Campus Dr
Stanford, California 94305
Stanford, California 94305
(650) 725-3900
Principal Investigator: Jean Tang, MD, PhD
Phone: 650-721-7149
Stanford University School of Medicine Vast in both its physical scale and its impact on...
Click here to add this to my saved trials
